TABLE 3.

Details of follow-up for seven cases in which the radiologist noted an abnormality not seen by the endoscopic retrograde cholangiopancreatography (ERCP) endoscopist

Case	Sex	Age, years	Symptoms or signs at ERCP	Findings ± therapy per endoscopy report	Findings per radiology report	Follow-up post-ERCP
1	Female	59	Abdominal pain Abnormal LEs Dilated CBD	Dilated CBD Normal PD Passed CBD stone*	Dilated CBD PD stone*	No symptoms at 12 months
2	Male	67	Abnormal LEs	Normal CBD and intrahepatic ducts	Sclerosing cholangitis*	Normal LEs at 12 months
3	Female	56	Abdominal pain	Dilated CBD Normal PD	Distal CBD stricture*	Abdominal pain unchanged at three months
4	Male	49	Hodgkin’s lymphoma with cholestasis on liver biopsy Jaundice (bilirubin level >6× normal)	Normal CBD and intrahepatic ducts	CBD stone	No abdominal pain Bilirubin level decreased to 1.5× normal LEs 5× normal at 5 months
5	Female	72	Elevated isolated GGT (other LEs and bilirubin level normal) History of ‘ampullary stenosis’ treated with sphincterotomy	Dilated CBD Sphincterotomy extended	CBD stricture	GGT unchanged at three months Other LEs and bilirubin level still normal
6	Female	45	Abdominal pain Suspected SOD	Normal CBD Normal PD Normal SOM	Normal CBD Normal PD Abnormal right main hepatic duct*	No symptoms at one month
7	Female	25	Recurrent pancreatitis	Normal CBD Normal PD Abnormal biliary SOM Biliary sphincterotomy performed	CBD stone	Acute pancreatitis at two months with normal LEs Repeat ERCP at three months determined normal CBD with abnormal pancreatic SOM, and LE still normal

^*Inconsistent finding between endoscopy reports and radiology report. CBD Common bile duct; PD Main pancreatic duct; GGT Gamma-glutamyl transpeptidase; LEs Liver enzymes; SOD Sphincter of Oddi dysfunction; SOM Sphincter of Oddi manometry